NH

Nedermaas Hightech Ventures

Europe, Limburg, The Netherlands, Maastricht

Description

Nedermaas Ventures focuses on pre-seed and seed investment opportunities across a broad spectrum of high technology fields.

Investor Profile

Nedermaas Hightech Ventures has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Undisclosed, Series C rounds (top funding stages).
  • Majority of deals are located in The Netherlands, France, United Kingdom.
  • Strong thematic focus on Biotechnology, Life Science, Therapeutics.

Stage Focus

  • Series Unknown (38%)
  • Undisclosed (25%)
  • Series C (13%)
  • Series A (13%)
  • Seed (13%)

Country Focus

  • The Netherlands (75%)
  • France (13%)
  • United Kingdom (13%)

Industry Focus

  • Biotechnology
  • Life Science
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Genetics
  • Health Care
  • Manufacturing
  • Agriculture
  • Chemical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nedermaas Hightech Ventures frequently co-invest with?

Aglaia BioMedical Ventures
Europe, Utrecht, The Netherlands, Bilthoven
Co-Investments: 1
NV Industriebank LIOF
Europe, Limburg, The Netherlands, Maastricht
Co-Investments: 3
Droia Ventures
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
DSM Venturing
Europe, Limburg, The Netherlands, Heerlen
Co-Investments: 1
BOM
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 1
Limburg Ventures
Europe, Limburg, The Netherlands, Maastricht
Co-Investments: 5
Sofimac Investment Managers
Europe, Auvergne, France, Clermont-ferrand
Co-Investments: 1
BioGeneration Ventures
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
UU
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2
Chemelot Ventures
Europe, Limburg, The Netherlands, Urmond
Co-Investments: 3

Which angels does Nedermaas Hightech Ventures often collaborate with?

JM
Europe, Guernsey
Shared Deals: 1
SH
Europe, England, United Kingdom, London
Shared Deals: 1
KP
Europe, England, United Kingdom, London
Shared Deals: 1
EK
Europe, Limburg, The Netherlands, Maastricht
Shared Deals: 1
HV
Europe, Limburg, The Netherlands, Maastricht
Shared Deals: 1

What are some of recent deals done by Nedermaas Hightech Ventures?

Cristal Therapeutics

Maastricht, Limburg, The Netherlands

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownJan 19, 2017
Amount Raised: $13,643,525
Cristal Therapeutics

Maastricht, Limburg, The Netherlands

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownDec 15, 2014
Amount Raised: $7,464,376
Enzypep

Geleen, Limburg, The Netherlands

Enzypep designs and develops oligopeptides for pharmaceutical products.

BiotechnologyGeneticsHealth CareLife ScienceManufacturing
UndisclosedJan 1, 2014
Ekompany

Born, Limburg, The Netherlands

Ekompany is a Dutch producer of coated mineral fertilisers (CRF) with sales operations in Western Europe and Far East.

AgricultureChemicalEnergy EfficiencyManufacturing
Series UnknownMar 6, 2013
Amount Raised: $14,547,930
Phenospex

Heerlen, Limburg, The Netherlands

Phenospex designs sensors and imagery analytics to extract quantitative metrics about the shape, health, and yield potential of crops.

AgricultureLife Science
SeedDec 13, 2011
Amount Raised: $653,805
BioActor

Maastricht, Limburg, The Netherlands

BioActor develops proprietary health ingredients for use in functional foods, medical nutrition, and dietary supplements.

BiotechnologyDietary SupplementsHealth Care
Series AJul 26, 2011
Amount Raised: $2,899,891
Q Chip

Cardiff, Cardiff, United Kingdom

Q Chip develops a range of sustained-release biogeneric and biotherapies products.

BiotechnologyLife ScienceTherapeutics
Series CMay 20, 2011
Amount Raised: $6,000,000
CellMade

Chappes, Auvergne, France

CellMade develops and commercializes cell biology products and services: human-origin primary cells and co-culture models.

BiotechnologyGeneticsLife Science
UndisclosedOct 1, 2010
Amount Raised: $2,339,806